K193288

Substantially Equivalent

Koya Ripple

Applicant: Koya, Inc.
Product code: JOW
Advisory panel: Cardiovascular
Date received: 2019-11-27
Decision date: 2020-06-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Francisco, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.